Stockhead

Dr Boreham’s Crucible: Late-stage clinical trial curse strikes Cynata Therapeutics

After a double whammy blow, Cynata is “actively reviewing” alternative uses for its Cymerus platform technology.

Humanoid robot startup Agility Robotics is going public at a $2.5 billion valuation via a SPAC

Agility Robotics aims to go public via a $2.5 billion SPAC merger, focusing on expanding its humanoid Digit robots.